|Advanced Medical Solutions
||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Advanced Medical Solutions Share Discussion Threads
Showing 6951 to 6972 of 6975 messages
|I sat across the table from then the last CEO and Penny 6 years ago and said I felt this ought to be a £500m company. Glad to see it|
|IMHO AMS will be looking very attractive to a large pharma, cash in the bank with a good product line and massive potential in the USA.|
|Makes you wonder what people were expecting?|
|Good set of solid results, increased dividend + "I am pleased to report a 20% increase in revenue to £82.6 million (2015: £68.6 million), representing growth of 13% on a constant currency basis and an increase in adjusted6 profit before tax before exceptional items of 13% to £19.7 million (2015: £17.4 million), and an increase in profit before taxation of 12% to £19.1million (2015: £17.0 million). The continued strong cash flow generation of the business has resulted in the Group ending the year with net cash of £51.1 million (2015: £34.2 million)."|
|I was wondering if they had been tipped but I suppose they are rising into the results next week|
|Can you enlarge on tipped `robow`, let us hope that the results are as good as the share price rise this week.|
|Can sell at 242.05, as I did, just a portion of 1000, at 9:56.|
"A medical superglue developed by a British company for surgeons to use in operations instead of sutures or staples could be on the market for the first time as early as next year.
Advanced Medical Solutions (AMS), a Cheshire-based maker of wound dressings and surgical equipment, developed the glue, called Liquiband Fix8, at its manufacturing and R&D facility in Plymouth.
It’s already being used by surgeons in Europe doing laparoscopic hernia operations, whereby a mesh is glued to a patient’s tissue, instead of using sharp staples or tacks, which can be painful for a patient after surgery.
However, Aim-listed AMS is now working with surgeons in the UK to test the glue in other areas of surgery – general, orthopaedics and obstetrics and gynaecology."
|Numis upgraded their recommendation from hold to buy.|
|Does anyone know what lit the fire under AMS today..?|
|Worried we were heading for a lower high, but that doesn't seem to be happening.|
|If the results are as the trading statement would suggest, what share price are we looking to achieve after the results announcement ?|
|LOL ... Yes, I knew we made a glue gun ...|
|There, you see, it wasn't a "big step" :-)
|Thanks for clarifying ...|
I didn't know we made/supplied (hernia?) mesh ???|
Mr Steinmann was appointed as Non-Executive Director of AMS in July 2013. He is a Swiss national with over twenty years of commercial experience in Medical Devices and Diagnostics. He has held senior roles within Johnson & Johnson, Medtronic International and Boehringer Mannheim. Most recently, he was Regional Vice President Global Surgery and Shared Services, Medical Devices and Diagnostics, Austria, Germany and Switzerland at Johnson & Johnson AG, Switzerland as well as Chairman of the Board.
|J&J have has problems with mesh suppliers. They might well be interested.
|See Norbus (above) ....|
|Bit nerve-wracking this rise. Which way will it go medium term? I'm no chartist but a lower low does seem possible (if no news), as does a gap up to over 250 if the J&J and similar rumours hold the day.|